Cargando…

COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm

Detalles Bibliográficos
Autor principal:	Gollob, Michael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American College of Cardiology Foundation. Published by Elsevier. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213956/ https://www.ncbi.nlm.nih.gov/pubmed/32407770 http://dx.doi.org/10.1016/j.jacc.2020.05.008

Ejemplares similares

No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
por: Demmel, Valentin, et al.
Publicado: (2018)

Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects
por: Ring, Arne, et al.
Publicado: (2013)

Randomized, Controlled, Thorough QT/QTc Study Shows Absence of QT Prolongation with Luseogliflozin in Healthy Japanese Subjects
por: Kumagai, Yuji, et al.
Publicado: (2015)

The Prophylactic Effects of Metoprolol, Diltiazem, and Pilocarpine on Hypoglycemia-Induced Prolongation of QT Interval
por: Cagiltay, Eylem, et al.
Publicado: (2021)

Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QT(c) interval in healthy subjects
por: Darpö, Börje, et al.
Publicado: (2013)

Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects
por: Green, Justin A, et al.
Publicado: (2014)

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
por: Shinozawa, Tadahiro, et al.
Publicado: (2017)

Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects
por: Hong, Taegon, et al.
Publicado: (2015)

QT prolongation in the STREAM Stage 1 Trial
por: Hughes, G., et al.
Publicado: (2022)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

No QTc Prolongation With Zanubrutinib: Results of Concentration‐QTc Analysis From a Thorough QT Study in Healthy Subjects
por: Mu, Song, et al.
Publicado: (2020)

Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study
por: Borin, Marie T., et al.
Publicado: (2019)

COVID-19: First Do No Harm
por: Waterer, Grant W., et al.
Publicado: (2020)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Acute effects of coffee on QT interval in healthy subjects
por: Buscemi, Silvio, et al.
Publicado: (2011)

2389. Effect of Rezafungin on QT Interval in Healthy Subjects
por: Flanagan, Shawn, et al.
Publicado: (2018)

Diabetes Drug Therapy -- First Do No Harm
por: Curtiss, Frederic R., et al.
Publicado: (2008)

First do not harm
por: Jamoulle, Marc
Publicado: (2015)

First, do no harm
por: Marler, Thomas E., et al.
Publicado: (2017)

First do no harm
por: Huisman, Menno V., et al.
Publicado: (2022)

Antipsychotic Medication and QT Prolongation
por: Chohan, Paramdip Singh, et al.
Publicado: (2015)

QT Prolongation in Cancer Patients
por: Kim, Peter, et al.
Publicado: (2021)

QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria
por: Akintunde, Adeseye A., et al.
Publicado: (2012)

Delayed Ventricular Tachycardia After Prophylactic Doses of Droperidol in Patients With Mild QT Interval Prolongation Due to Preoperative Medication
por: Takechi, Kenichi, et al.
Publicado: (2021)

Managing drug-induced QT prolongation in clinical practice
por: Khatib, Rani, et al.
Publicado: (2021)

On language – first, do no harm
por: Schumann, Roman
Publicado: (2022)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

QT Prolongation due to Graves' Disease
por: Kulairi, Zain, et al.
Publicado: (2017)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Trousseau’s sign and QT prolongation in hypocalcaemia
por: Schnur, Jack, et al.
Publicado: (2021)

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
por: Rowe, Elizabeth J., et al.
Publicado: (2022)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Sex and Rate Change Differences in QT/RR Hysteresis in Healthy Subjects
por: Andršová, Irena, et al.
Publicado: (2022)

Concentration‐QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations
por: Voronova, Veronika, et al.
Publicado: (2021)

Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation
por: Jolling, Koen, et al.
Publicado: (2019)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

A Case of QT Prolongation Associated with Panhypopituitarism
por: Arpaci, Dilek, et al.
Publicado: (2013)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

Energy Drinks: Another Cause of QT Prolongation?
por: Winniford, Michael D.
Publicado: (2019)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b8o65uns4jh3aubitj89r2qrak